AU2002368044A1 - Co-stimulatory molecules - Google Patents

Co-stimulatory molecules

Info

Publication number
AU2002368044A1
AU2002368044A1 AU2002368044A AU2002368044A AU2002368044A1 AU 2002368044 A1 AU2002368044 A1 AU 2002368044A1 AU 2002368044 A AU2002368044 A AU 2002368044A AU 2002368044 A AU2002368044 A AU 2002368044A AU 2002368044 A1 AU2002368044 A1 AU 2002368044A1
Authority
AU
Australia
Prior art keywords
stimulatory molecules
stimulatory
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368044A
Other languages
English (en)
Other versions
AU2002368044A8 (en
Inventor
Doris Apt
Jean Chia-Chun Chang
Claes Gustafsson
Alexandra L. L. Lazetic
Steven R. Leong
Juha Punnonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen Inc
Original Assignee
Maxygen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/888,324 external-priority patent/US7094875B2/en
Priority claimed from US10/032,214 external-priority patent/US7183376B2/en
Application filed by Maxygen Inc filed Critical Maxygen Inc
Publication of AU2002368044A1 publication Critical patent/AU2002368044A1/en
Publication of AU2002368044A8 publication Critical patent/AU2002368044A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002368044A 2001-06-22 2002-06-21 Co-stimulatory molecules Abandoned AU2002368044A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AUPCT/US2001/019973 2001-06-22
US09/888,324 2001-06-22
US09/888,324 US7094875B2 (en) 2000-06-23 2001-06-22 Co-stimulatory polypeptides
PCT/US2001/019973 WO2002000717A2 (fr) 2000-06-23 2001-06-22 Nouvelles molecules costimulatrices
US10/032,214 2001-12-20
US10/032,214 US7183376B2 (en) 2000-06-23 2001-12-20 Variant B7 co-stimulatory molecules
PCT/US2002/019898 WO2004029197A2 (fr) 2001-06-22 2002-06-21 Nouvelles molecules co-stimulatrices

Publications (2)

Publication Number Publication Date
AU2002368044A1 true AU2002368044A1 (en) 2004-04-19
AU2002368044A8 AU2002368044A8 (en) 2004-04-19

Family

ID=56290305

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368044A Abandoned AU2002368044A1 (en) 2001-06-22 2002-06-21 Co-stimulatory molecules

Country Status (3)

Country Link
EP (1) EP1497426A2 (fr)
AU (1) AU2002368044A1 (fr)
WO (1) WO2004029197A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3640375A3 (fr) 2012-12-11 2020-07-29 Albert Einstein College of Medicine Procédés pour identification de récepteur/ligand à rendement élevé
SI3283508T1 (sl) 2015-04-17 2021-09-30 Alpine Immune Sciences, Inc. Imunomodulirajoči proteini z nastavljivimi afinitetami
US10273281B2 (en) 2015-11-02 2019-04-30 Five Prime Therapeutics, Inc. CD80 extracellular domain polypeptides and their use in cancer treatment
MA43552A (fr) 2016-04-15 2018-11-07 Alpine Immune Sciences Inc Protéines immunomodulatrices à variants de cd80 et leurs utilisations
CA3022331A1 (fr) 2016-05-18 2017-11-23 Albert Einstein College Of Medicine, Inc. Variants de polypeptides pd-l1, polypeptides multimeres modulateurs des lymphocytes t et procedes d'utilisation correspondants
SG11201808552XA (en) 2016-05-18 2018-10-30 Cue Biopharma Inc T-cell modulatory multimeric polypeptides and methods of use thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
WO2018022945A1 (fr) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Protéines immunomodulatrices à variants de cd112 et utilisations associées
IL266696B2 (en) 2016-12-22 2023-04-01 Cue Biopharma Inc Multimeric polypeptides modulate t cells and methods for their use
WO2018129474A1 (fr) 2017-01-09 2018-07-12 Cue Biopharma, Inc. Polypeptides multimères modulateurs de lymphocytes t et leurs procédés d'utilisation
KR102619015B1 (ko) 2017-03-15 2023-12-28 큐 바이오파마, 인크. 면역 반응을 조절하는 방법
MX2019010887A (es) 2017-03-16 2019-10-15 Alpine Immune Sciences Inc Proteinas inmunomoduladoras de cb80 variante y usos de estas.
EP3596115A1 (fr) 2017-03-16 2020-01-22 Alpine Immune Sciences, Inc. Protéines immunomodulatrices à variants pd-l2 et utilisations associées
EP3628070B1 (fr) 2017-04-28 2021-09-08 Five Prime Therapeutics, Inc. Polypeptides du domaine extracellulaire de cd80 pour l'utlisation dans l'augmentation de lymphocytes t de mémoire centrale
EA202090974A1 (ru) 2017-10-18 2020-08-05 Элпайн Иммьюн Сайенсиз, Инк. Вариантные иммуномодулирующие белки лиганда icos и сопутствующие композиции и способы
WO2019139896A1 (fr) 2018-01-09 2019-07-18 Cue Biopharma, Inc. Polypeptides multimères modulateurs de lymphocytes t et leurs procédés d'utilisation
CN112673093A (zh) * 2018-07-04 2021-04-16 赛通免疫治疗公司 靶向flt3、pd-1和/或pd-l1的免疫疗法的组合物和方法
MA53651A (fr) * 2018-09-19 2021-07-28 Alpine Immune Sciences Inc Méthodes et utilisations de protéines de fusion de variant cd80 et constructions associées
TW202208395A (zh) 2020-05-12 2022-03-01 美商信號生物製藥公司 多聚體ｔ細胞調節多肽及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429303B1 (en) * 1999-09-03 2002-08-06 Curagen Corporation Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
EP1360290A2 (fr) * 2000-06-23 2003-11-12 Maxygen, Inc. Molecules costimulatrices

Also Published As

Publication number Publication date
WO2004029197A3 (fr) 2004-10-28
WO2004029197A2 (fr) 2004-04-08
EP1497426A2 (fr) 2005-01-19
AU2002368044A8 (en) 2004-04-19
WO2004029197A8 (fr) 2005-07-21

Similar Documents

Publication Publication Date Title
AU2002313565A1 (en) Putter-heads
AU2002368044A1 (en) Co-stimulatory molecules
AU2002245332A1 (en) Anergy-regulated molecules
AU2002337312A1 (en) Molecules
AU2002359320A1 (en) Novel anit-infectives
AU2002319532A1 (en) Feeding-bottles
AU2002313943A1 (en) Electromobile
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AU2002313073A1 (en) Phytocystatin
AU2002257925A1 (en) Numberplates
AU2002100746A4 (en) Adrail
AU2001100214A4 (en) Dolly-trolley
AU2001100338A4 (en) Sunglove
AU2001100522A4 (en) e-Trans
AU2001100532A4 (en) FonePark
AU2002316594A1 (en) Minimizing spatial-dispersion-induced birefringence
AUPR754901A0 (en) Masta technologies
AU2002253663A1 (en) Novel maxizyme
AU2002254979A1 (en) Novel sulfonylamino-pyrimidines
AU2002355888A1 (en) Novel combination
AU2002235675A1 (en) Regakine-1
AU2002319649A1 (en) R-6-hydroxy-buspirone
AU2002305440A1 (en) Piperazinyl-isatins
AU2002316748A1 (en) S-6-hydroxy-buspirone

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase